HBV
Good Results With Biktarvy in HIV–HBV Coinfection
At CROI 2025, Dr. Anchalee Avihingsanon and her colleagues reported Week 48 outcomes from the open-label extension ...
MARCH 25, 2025
Pharmacist Recommendations Improve Oral Oncolytic HBV Screening
The vast majority of providers accept pharmacist-initiated recommendations to screen for hepatitis B virus in ...
DECEMBER 16, 2024
High Virologic Suppression Seen With DTG/3TC Among Patients With Reactive HBV Core Antibody
Dovato demonstrates high rates of virologic suppression among people living with HIV and who have reactive anti-HBc ...
JULY 24, 2024
Treating All U.S. HBV Pts Could Be a Big Cost-Saver
Treating all U.S. patients infected with hepatitis B virus (HBV) would significantly decrease disease burden and ...
OCTOBER 20, 2022
FDA Approves PreHevbrio 3-Antigen HepB Vaccine
PreHevbrio is indicated for the prevention of infection caused by all known subtypes of HBV in adults 18 years of ...
DECEMBER 3, 2021
ACIP Recommends ‘Universal’ Adult HBV Vaccine—But Not for All
The risk-based vaccination strategy has been partially successful with initial decreases, but new HBV infections ...
NOVEMBER 18, 2021
HBV Meds Affordable and Available, yet Treatment Lags
Many people living with HBV lack adequate treatment.
AUGUST 3, 2018
Aspirin Lowers HCC Risk in Hep B Patients
Daily aspirin is significantly associated with a reduced risk for liver cancer in patients with hepatitis B virus, ...
APRIL 4, 2018
Indigenous People More Likely to Be Infected by HBV and/or HCV Than Others
A new meta-analysis of global hepatitis data shows that indigenous peoples are up to 10 times more likely to be ...
AUGUST 10, 2017
HBV, HCV May Increase Parkinson’s Risk
Patients with HBV were 76% more likely to develop Parkinson’s disease and those with HCV were 51% more likely ...
APRIL 12, 2017
CDC: Sharing Needles Increases HIV, HCV and HBV Risk
One consequence of the nation’s devastating opioid epidemic is the increased risk for HIV, HCV and HBV ...
NOVEMBER 29, 2016
FDA Approves Gilead’s Vemlidy To Treat Chronic HBV
Vemlidy is a once-daily treatment that demonstrated similar efficacy with improved renal and bone laboratory safety ...
NOVEMBER 18, 2016
